Trinity Biotech Return on Equity:
10.77% for Dec. 31, 2012Trinity Biotech Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 10.77% |
| Sept. 30, 2012 | 10.78% |
| June 30, 2012 | 10.69% |
| March 31, 2012 | 10.62% |
| Dec. 31, 2011 | 10.63% |
| Sept. 30, 2011 | 10.58% |
| June 30, 2011 | 10.10% |
| March 31, 2011 | 47.87% |
| Dec. 31, 2010 | 52.81% |
| Sept. 30, 2010 | 59.20% |
| June 30, 2010 | 68.00% |
| March 31, 2010 | 16.55% |
| Dec. 31, 2009 | 16.38% |
| Sept. 30, 2009 | -85.10% |
| June 30, 2009 | -74.74% |
| March 31, 2009 | -67.27% |
| Dec. 31, 2008 | -61.08% |
| Sept. 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
TRIB Return on Equity Benchmarks
| Companies | |
|---|---|
| Meridian Bioscience | 25.23% |
| SurModics | 9.33% |
| Abaxis | 16.24% |
TRIB Return on Equity Rankings
| Overall |
77th percentile 1709 of 7593 |
| Sector |
78th percentile 142 of 650 in Healthcare |
| Industry |
72nd percentile 17 of 61 in Diagnostics & Research |
TRIB Return on Equity Range, Past 5 Years
| Minimum | -85.10% | Sep 2009 |
| Maximum | 68.00% | Jun 2010 |
| Average | 2.75% |
